The surgical robots market comprises advanced robotic systems that assist surgeons in performing complex and minimally invasive procedures with greater precision, control, and flexibility. Widely used in fields such as orthopedics, urology, gynecology, and cardiology, these systems offer benefits like smaller incisions, reduced blood loss, faster recovery, and improved patient outcomes. Market growth is fueled by rising demand for minimally invasive surgeries, technological innovations including AI integration and enhanced imaging, and increasing adoption in hospitals and specialty clinics worldwide, although high costs and the need for specialized training remain key challenges.

According to Fortune Business Insights, the global surgical robots market was valued at USD 1,463.0 million in 2018 and is projected to reach USD 22,381.6 million by 2032, exhibiting a compound annual growth rate (CAGR) of 21.5% during the forecast period (2018–2032). In 2018, North America dominated the market with a 71.46% share.

Top Companies in the Market

• Intuitive Surgical Inc.
• Medtronic
• Stryker
• Smith & Nephew
• Zimmer Biomet
• TransEnterix Surgical, Inc.
• Verb Surgical, Inc.
• THINK Surgical, Inc.
• Other Prominent Players

Key Industry Developments

• In May 2018, Intuitive Surgical Inc. received FDA clearance for the da Vinci X Surgical System, enabling urologic surgical procedures via a single-port approach.

Market Drivers & Restraints

Several key factors are propelling the surgical robots market forward:

• The growing preference for minimally invasive, robotic-assisted procedures, which offer precision and reduced patient trauma.
• Technological advancements, especially the development of procedure-specific robotic systems that address unique clinical needs—such as Intuitive’s "Ion" system for deep lung biopsies, recently approved by the U.S. FDA.
• Increasing adoption by healthcare professionals, driven by demand for accuracy, automation, and superior patient outcomes.